BroadOak Capital Partners
OTHER
INVESTOR TYPE
Active
STATUS
7
PROFESSIONALS
31
INVESTMENTS
13
PORTFOLIO
16
EXITS
Description
BroadOak Capital Partners is an investment bank that is also involved in growth equity, venture capital and mezzanine investments. The firm focuses on the life sciences industry, research tool and consumable, diagnostic, therapeutic and biotechnology sectors. The firm also provides banking and financial advisory services to corporate and institutional clients. It was founded on 2006 and is headquartered in Bethesda, Maryland.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2006
Primary Investor Type
Investment Bank
Other Investor Types
Growth/Expansion
Mezzanine
PE/Buyout
Venture Capital
Primary Office
- 4800 Montgomery Lane
- Suite 230
- Bethesda, MD 20814
- United States
+1 (301) 000-0000
BroadOak Capital Partners Investments (31)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Halo Labs | 20-Dec-2018 | Later Stage VC | 00.000 | Diagnostic Equipment | Generating Revenue | |
| 00000000000000 | 05-Nov-2018 | 00000 00000 | 0000 | Consulting Services (B2B) | Generating Revenue | 0000000 000000 |
| 00000000000000 | 05-Mar-2018 | 00000 00000 | 0000 | Consulting Services (B2B) | Generating Revenue | 0000000 000000 |
| 00000000 | 01-Jun-2017 | 00 000000000 | Biotechnology | Generating Revenue | ||
| 0000000000 | 01-Jun-2017 | 00 000000000 | 000.00 | Laboratory Services (Healthcare) | Profitable | 0000000 0000000 |
| 0000 0000 | 01-May-2017 | 00000 00000 | 00.00 | Diagnostic Equipment | Generating Revenue | |
| 00000 (000) | 01-Mar-2017 | 00 000000000 | Drug Discovery | Generating Revenue | ||
| 0000000000-000000. | 21-Oct-2016 | 00000 00000 | Social/Platform Software | Generating Revenue | ||
| Empire Genomics | 20-May-2016 | Later Stage VC | 00.000 | Drug Discovery | Generating Revenue | 0000000 000000 |
| Quad Technologies | 05-Nov-2015 | Early Stage VC | 00.000 | Therapeutic Devices | Generating Revenue |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore BroadOak Capital Partners’s full profile, request a free trial.
BroadOak Capital Partners Exits (16)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Gold Standard Diagnostics | 06-Jul-2018 | Merger/Acquisition | Completed |
|
|
| 0000 000000000000 | 07-Jun-2018 | 000000000000000000 | Completed |
|
|
| 000000000 | 23-May-2018 | 000000000000000000 | Completed |
|
|
| 0000000 00000000 | 17-Jan-2017 | 000000000000000000 | 0000 | Completed |
|
| 0000 000 | 29-Nov-2016 | 000000000000000000 | 0000 | Completed |
|
| 0000000 00000000 0 | 15-Jan-2015 | 000000000000000000 | Completed |
|
|
| 00000 | 28-May-2014 | 000000000000000000 | 0000 | Completed |
|
| 000000 0000000000 | 29-Jan-2014 | 000000000000000000 | Completed |
|
|
| Smithers Avanza | 01-Dec-2012 | Merger/Acquisition | Completed |
|
|
| Selah Genomics | 31-Dec-2009 | Merger/Acquisition | Completed |
BroadOak Capital Partners Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is reserved for PitchBook Platform accredited users. To explore BroadOak Capital Partners‘s full profile, request access.
Request full access to PitchBookBroadOak Capital Partners Team (12)
5 Former Team Members
You’re viewing 5 of 12 team members. Get the full list »BroadOak Capital Partners Co-Investors (13)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Current Yield with Participation Fund | 3 | 0 | |
| Research Corporation Technologies | 0 | 0 | |
| BioAdvance | 0 | 0 | |
| Rand Capital | 0 | 0 | |
| S-UBG | 0 |